TCGA identified pan-cancer driver pathways [10]: multiple RTKs; proliferation and growth (Ras/Raf/MEK/ERK; PI-3K/PTEN/AKT/mTOR); cell cycle; DNA damage. This evidence concerns the gene MAP2K7 and cancer.